SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001477932-24-002777
Filing Date
2024-05-13
Accepted
2024-05-13 16:29:09
Documents
13
Period of Report
2024-07-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A vnrx_def14a.htm DEF 14A 767705
2 vnrx_def14aimg9.jpg GRAPHIC 166066
3 vnrx_def14aimg8.jpg GRAPHIC 45226
4 vnrx_def14aimg7.jpg GRAPHIC 50307
5 vnrx_def14aimg6.jpg GRAPHIC 2992
6 vnrx_def14aimg5.jpg GRAPHIC 4468
7 vnrx_def14aimg4.jpg GRAPHIC 4833
8 vnrx_def14aimg3.jpg GRAPHIC 4428
9 vnrx_def14aimg2.jpg GRAPHIC 4449
10 vnrx_def14aimg12.jpg GRAPHIC 148268
11 vnrx_def14aimg11.jpg GRAPHIC 169952
12 vnrx_def14aimg10.jpg GRAPHIC 204732
13 vnrx_def14aimg1.jpg GRAPHIC 20616
  Complete submission text file 0001477932-24-002777.txt   1908325
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36833 | Film No.: 24939520
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)